Lipella Pharmaceuticals, Inc. (LIPO) Stock Statistics & Valuation Metrics
Total Valuation
Lipella Pharmaceuticals, Inc. has a market cap or net worth of $2,773.00. The enterprise value is -$1.34T.
- Market Cap
- $2,773.00
- Enterprise Value
- -$1.34T
Share Statistics
Lipella Pharmaceuticals, Inc. has 4,620,837 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 4,620,837
- Owned by Insiders
- ―
- Owned by Institutions
- 0.29%
Financial Efficiency
Lipella Pharmaceuticals, Inc.’s return on equity (ROE) is -2.61 and return on invested capital (ROIC) is -258.28%.
- Return on Equity (ROE)
- -2.61
- Return on Assets (ROA)
- -1.88
- Return on Invested Capital (ROIC)
- -258.28%
- Return on Capital Employed (ROCE)
- -2.65
- Revenue Per Employee
- 76.62K
- Profits Per Employee
- -716.61K
- Employee Count
- 7
- Asset Turnover
- 0.20
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Lipella Pharmaceuticals, Inc. is -0.00. Lipella Pharmaceuticals, Inc.’s PEG ratio is -0.00.
- PE Ratio
- -0.00
- PS Ratio
- 0.00
- PB Ratio
- 0.00
- Price to FCF
- -0.00
- Price to Operating Cash Flow
- -0.00
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Lipella Pharmaceuticals, Inc. had revenue of 536.36K and earned -5.02M in profits. Earnings per share was -4.79.
- Revenue
- 536.36K
- Gross Profit
- -3.08M
- Operating Income
- -5.08M
- Pretax Income
- -5.02M
- Net Income
- -5.02M
- EBITDA
- -5.01M
- Earnings Per Share (EPS)
- -4.79
Cash Flow
In the last 12 months, operating cash flow was -2.36B and capital expenditures 0, giving a free cash flow of -2.36B billion.
- Operating Cash Flow
- -2.36B
- Free Cash Flow
- -2.36B
- Free Cash Flow per Share
- -518.60
Dividends & Yields
Lipella Pharmaceuticals, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -85077353.05%
- Earnings Yield
- -94581.08%
Stock Price Statistics
- Beta
- 3.25
- 52-Week Price Change
- -94.58%
- 50-Day Moving Average
- 0.07
- 200-Day Moving Average
- 0.16
- Relative Strength Index (RSI)
- 36.87
- Average Volume (3m)
- 1,461
Financial Position
Lipella Pharmaceuticals, Inc. as a current ratio of 3.47, with Debt / Equity ratio of 2.48%
- Current Ratio
- 3.47
- Quick Ratio
- 3.47
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.43
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Lipella Pharmaceuticals, Inc. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Lipella Pharmaceuticals, Inc. EV to EBITDA ratio is 0.62, with an EV/FCF ratio of 0.00.
- EV to Sales
- 0.00
- EV to EBITDA
- 0.62
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Lipella Pharmaceuticals, Inc. has $1.86M in cash and marketable securities with $264.08K in debt, giving a net cash position of $1.59M billion.
- Cash & Marketable Securities
- $1.86M
- Total Debt
- $264.08K
- Net Cash
- $1.59M
- Net Cash Per Share
- $0.34
- Tangible Book Value Per Share
- $0.33
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
